UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
19.74
-0.34 (-1.69%)
At close: Aug 15, 2025, 3:59 PM
19.50
-1.22%
After-hours: Aug 15, 2025, 06:59 PM EDT
UroGen Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 92.9M | 104.03M | 171.99M | 124.92M | 220.8M | 132.26M | 95.82M | 119.31M | 20.13M | 36.54M | 55.41M | 28.69M | 80.69M | 105.38M | 44.36M | 55.34M | 63.32M | 40.49M |
Short-Term Investments | 64.05M | 91.86M | 64.7M | 124.66M | 21.11M | 32.61M | 41.97M | 28.11M | 27.17M | 28.51M | 44.56M | 67.22M | 31.05M | 31.07M | 44.78M | 50.87M | 57.71M | 35.42M |
Long-Term Investments | 4.81M | 4.51M | 5.02M | 4.64M | 378K | 707K | 4.73M | 6.51M | 7.97M | 10.16M | 223K | 223K | 673K | 674K | 675K | 4.07M | 8.29M | 223K |
Other Long-Term Assets | 801K | 547K | 765K | 545K | 673K | 1.1M | 2.04M | 2.27M | 3.04M | 3.38M | 2.74M | 2.47M | 2.12M | 1.79M | 1.53M | 2M | 1.33M | 66K |
Receivables | 19.65M | 19.64M | 20.3M | 22.8M | 17.41M | 14.16M | 15.44M | 12.85M | 15.51M | 12.49M | 12.7M | 9.43M | 11.6M | 9.5M | 11.72M | 7.78M | 9.51M | 6.3M |
Inventory | 7.13M | 7.59M | 9.23M | 7.59M | 7.44M | 7.24M | 5.67M | 5M | 4.99M | 5.47M | 4.33M | 4.86M | 5.05M | 4.76M | 4.83M | 3.81M | 3.42M | 3.33M |
Other Current Assets | 13.14M | 14.06M | 9.92M | 15.13M | 12.21M | n/a | 10.28M | 817K | 13.54M | 12.96M | 11.91M | 812K | 811K | 550K | 1.23M | 1.23M | 1.23M | 1.23M |
Total Current Assets | 196.87M | 237.18M | 276.13M | 295.1M | 278.97M | 196.76M | 169.19M | 182.12M | 81.33M | 95.97M | 128.91M | 121.59M | 139.62M | 160.52M | 114.39M | 125.14M | 140.5M | 93.08M |
Property-Plant & Equipment | 6.24M | 5.38M | 3.79M | 1.66M | 1.83M | 2.01M | 2.36M | 2.73M | 3.02M | 3.43M | 3.75M | 4.18M | 3.72M | 2.72M | 3.15M | 3.4M | 3.65M | 4.04M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 11.85M | 10.44M | 9.58M | 6.85M | 2.88M | 3.81M | 9.13M | 11.51M | 14.03M | 16.98M | 6.71M | 6.88M | 6.52M | 5.19M | 5.36M | 9.46M | 13.27M | 4.33M |
Total Assets | 208.72M | 247.62M | 285.71M | 301.94M | 281.85M | 200.57M | 178.31M | 193.63M | 95.36M | 112.95M | 136.24M | 128.47M | 146.14M | 165.72M | 119.75M | 134.6M | 153.77M | 97.41M |
Account Payables | 13.56M | 14.57M | 10.93M | 5.56M | 8.32M | 6.26M | 6.51M | 4.04M | 4.66M | 6.97M | 5.53M | 2.54M | 2.46M | 4.23M | 5.79M | 4.06M | 4.83M | 6.1M |
Deferred Revenue | n/a | n/a | 5.15M | 7.7M | 6.43M | 5.24M | 4.39M | 2.71M | 2.72M | n/a | 618K | 687K | 679K | 361K | 497K | 847K | 712K | 449K |
Short-Term Debt | 1.55M | 1.41M | 1.53M | 825K | 796K | 779K | 819K | 858K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 32.44M | 10.26M | -263K | 9.68M | 2.45M | -2.82M | -1.35M | -15K | 2.73M | 8.1M | 2.33M | 2.08M | 2.96M | 4.01M | 3.33M | 2.27M | 1.94M | 1.74M |
Total Current Liabilities | 47.55M | 42M | 45.95M | 32.79M | 34.22M | 26.34M | 31.21M | 25.79M | 26.77M | 25.23M | 23.92M | 19M | 18.04M | 19.09M | 22.38M | 19.81M | 19.06M | 17M |
Long-Term Debt | 125.92M | 122.11M | 121.73M | 121.71M | 97.81M | 97.59M | 98.55M | 98.52M | 98.3M | 97.94M | 97.54M | 71.87M | 71.2M | 70.8M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 128.62M | 127.13M | 125.18M | 121.72M | 119.07M | 116.14M | 112.92M | 110.29M | 107.53M | 101.91M | 101.94M | 99.03M | 96.3M | 92.62M | 88.56M | 82.64M | 77.52M | 2.72M |
Total Long-Term Liabilities | 254.54M | 252.08M | 248.56M | 243.64M | 217.31M | 214.37M | 212.31M | 209.84M | 207.03M | 204.27M | 201.06M | 172.76M | 169.01M | 163.7M | 88.95M | 83.26M | 78.44M | 3.92M |
Total Liabilities | 302.09M | 294.08M | 294.51M | 276.43M | 251.53M | 240.71M | 243.52M | 235.63M | 233.79M | 229.51M | 224.98M | 191.76M | 187.05M | 182.79M | 111.33M | 103.07M | 97.5M | 20.92M |
Total Debt | 125.92M | 124.95M | 123.39M | 121.92M | 99.03M | 99.01M | 100.21M | 99.54M | 99.5M | 99.34M | 99.12M | 73.73M | 72.71M | 71.07M | 398K | 616K | 922K | 1.2M |
Common Stock | 126K | 126K | 115K | 115K | 112K | 99K | 89K | 84K | 64K | 64K | 63K | 63K | 62K | 62K | 61K | 61K | 61K | 61K |
Retained Earnings | -900M | -850.07M | -806.22M | -768.71M | -745.04M | -711.63M | -679.35M | -653.33M | -631.45M | -607.32M | -577.1M | -548.24M | -522.4M | -495.71M | -467.32M | -438.87M | -408.66M | -382.44M |
Comprehensive Income | 6K | 14K | 56K | 236K | -31K | -37K | 12K | -134K | -154K | -45K | -107K | -155K | -56K | -69K | -25K | 4K | 45K | 143K |
Shareholders Equity | -93.38M | -46.46M | -8.8M | 25.52M | 30.31M | -40.13M | -65.21M | -41.99M | -138.43M | -116.55M | -88.74M | -63.29M | -40.91M | -17.07M | 8.41M | 31.54M | 56.27M | 76.49M |
Total Investments | 68.86M | 96.37M | 69.72M | 129.3M | 21.48M | 33.31M | 46.69M | 34.62M | 27.17M | 38.68M | 44.56M | 67.22M | 31.72M | 31.74M | 44.87M | 54.94M | 66M | 35.42M |